Five-year survival outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC: An update from the PACIFIC trial.

Spigel D. R., Faivre-Finn C., Gray J. E., Vicente D., Planchard D., Paz-Ares L. G., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.39, sa.15, 2021 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Özet
• Cilt numarası: 39 Sayı: 15
• Basım Tarihi: 2021
• Doi Numarası: 10.1200/jco.2021.39.15_suppl.8511
• Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
• İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır